Atamyo Therapeutics
@atamyotx
Our mission: to bring a new generation of best-in-class gene therapies to patients suffering from neuromuscular diseases.
ID: 1450950143629430787
http://atamyo.com 20-10-2021 22:21:28
35 Tweet
218 Followers
241 Following
It's #LGMD Awareness Day! GENETHON France , Isabelle Richard and her team have been working on LGMDs for over 30 years. One #GeneTherapy product is currently in trial for #FKRP LGMD. A trial conducted by Atamyo Therapeutics , a Genethon spin-off 👉bit.ly/3Cmjk3W
It's #LGMD Awareness Day! Atamyo Therapeutics Isabelle Richard and her team have been working on LGMDs for over 30 years. One #GeneTherapy product is currently in trial for #FKRP LGMD. A trial conducted by Atamyo Therapeutics. Proud to develop treatments for this devastating disease
#CGMed23 tomorrow at 4PM Atamyo Therapeutics company update by CEO Stephane Degove. Hope to see you there. #GeneTherapy
Atamyo Therapeutics announces appointment of Roger Hajjar, MD, Dir of the Gene and Cell Therapy Institute of Mass General Brigham to it’s Board of Directors. Dr. Hajjar is a gene therapy pioneer and internationally recognized scientist. atamyotx.com #genetherapy #LGMD
Another key milestone reached for Atamyo Therapeutics and for the #LGMD community, this time with a potential one-time treatment for the devastating LGMD2C/R5 disease. #genetherapy #musculardystrophy
Atamyo Therapeutics stands by the #LGMD Community and reiterates its full commitment to develop treatments for LGMD and to better describe how this disease affects patients' lives. #LgmdAwareness #genetherapy
Atamyo Therapeutics approved to initiate #clinicaltrial of ATA-200 in France and Italy. ATA-200 single-injection #genetherapy aimed to treat LGMD2C/R5 caused by mutations in the g-sarcoglycan gene. Ph1b study to evaluate safety and efficacy in children. bit.ly/3U440SB #LGMD
ICYMI: The trial, which will take the form of a dose escalation study, is expected to enroll 6 participants in total. #MuscularDystrophy #genetherapy #LimbGirdleMuscularDystrophy Atamyo Therapeutics Read more: cgtlive.com/view/atamyo-li…
Atamyo Therapeutics #LGMD programs featured in scientific presentations at #Myology2024. #genetherapy Details: bit.ly/49TzQFX . .
Atamyo Therapeutics is proud to announce this new partnership with The Dion Foundation to expand our first-in-human trial of ATA-200 #genetherapy to treat LGMD2C/R5 in the US. Read full press release here: bit.ly/3ZdZmEi #LGMD #MuscularDystrophy